Pfizer refuses to withdraw Bextra, even after fatal side effects ...
449178
US regulators warned yesterday of possible heart risks with Pfizer&#39;s Bextra, delivering another blow to popular pain drugs cox-2 inhibitors such as Vioxx, withdrawn from the market by Merck in September.
341280
Pfizer Inc.'s painkiller Bextra will  come with a new warning about the possibility of heart attacks  and blood clots in patients who have just had heart bypass  surgery, the U.S. Food and Drug Administration said on  Thursday.
446964
WASHINGTON (CBS.MW) -- The US Food and Drug Administration said on Thursday that Pfizer&#39;s new pain drug Bextra will carry a labeled warning about a risk of cardiac and blood-clotting problems.
117545
AstraZeneca Plc AZN.L AZN.N on  Friday said U.S. regulators did not approve its anti-clotting  drug Exanta.
15055
AstraZeneca Plc (AZN) on Friday said US regulators did not approve its anti-clotting drug Exanta. The US Food and Drug Administration followed the advice of an advisory panel, which last
625109
Doctors writing in a prominent medical  journal on Friday recommended that physicians stop prescribing  Pfizer Inc.'s Bextra painkiller, just as a large study found  the drug maker's sister drug, Celebrex, doubled risk of heart  attacks.
515226
A federal judge denied a request by Pfizer (nyse: PFE - news - people ) to halt competitors&#39; sales of gabapentin, a generic form of Pfizer&#39;s Neurontin epilepsy drug.
469532
Judge is expected to decline motion to block a generic version of Pfizer&#39;s $3B epilepsy drug. CHICAGO  - Pfizer Inc. shares tumbled Thursday as investors worried a federal judge will refuse the company&#39;s
270105
Patients given PfizerÂs painkiller Bextra have more than twice as many heart attacks and strokes as those given placebos, according to preliminary results of a study.
606693
Doctors writing in a prominent medical  journal on Friday recommended that physicians stop prescribing  Pfizer Inc.'s Bextra painkiller, just as a large study found  the drugmaker's sister drug, Celebrex,  doubled risk of heart  attacks.
140812
WASHINGTON (CBS.MW) - An advisory panel to the Food and Drug Administration late Friday declined to endorse AstraZeneca&#39;s anti-stroke drug, Exanta.
573622
FRIDAY, Oct. 8 (HealthDayNews) -- A week after drug giant Merck & Co. withdrew its arthritis drug Vioxx from the market, doubts are being raised about the safety of the two other approved medications in this class, Bextra and Celebrex.
225087
NEW YORK - Since Merck&#39;s Vioxx was pulled from the market for increasing the risk of heart attack and stroke in a long-term study, there has been heated debate over whether other, similar medicines, such as Pfizer&#39;s Celebrex and Bextra, carry similar risks
482981
NEW YORK - Pfizer Inc. said it found an increased risk of heart attacks for patients taking high dosages of its top-selling painkiller Celebrex, the same problem that led to the withdrawal of its one-time competitor Vioxx.
352014
Pfizer Inc. will warn doctors that its Bextra painkiller, which is in the same group of drugs as Merck &amp; Co.&#39;s withdrawn Vioxx, is linked to an elevated risk of blood clots, heart attacks and strokes in cardiac-surgery patients.
80575
Drugmaker Pfizer Inc. is in talks with  regulators over a likely change to arthritis drug Bextra's  label to carry the strictest possible warning alerting doctors  of the risk of a potentially deadly skin reaction, the company  said in a regulatory filing.
395069
The news seemingly keeps getting worse for Pfizer (NYSE: PFE), but if it can relieve investors&#39; anxiety, the pharmaceutical company stands to be stronger than ever.